AU2001232819A1 - Novel dyes - Google Patents
Novel dyesInfo
- Publication number
- AU2001232819A1 AU2001232819A1 AU2001232819A AU3281901A AU2001232819A1 AU 2001232819 A1 AU2001232819 A1 AU 2001232819A1 AU 2001232819 A AU2001232819 A AU 2001232819A AU 3281901 A AU3281901 A AU 3281901A AU 2001232819 A1 AU2001232819 A1 AU 2001232819A1
- Authority
- AU
- Australia
- Prior art keywords
- therapy
- detection
- imaging
- dyes
- useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000975 dye Substances 0.000 title abstract 4
- 238000002560 therapeutic procedure Methods 0.000 abstract 5
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 238000001514 detection method Methods 0.000 abstract 3
- 238000003384 imaging method Methods 0.000 abstract 3
- 230000003287 optical effect Effects 0.000 abstract 2
- 230000005856 abnormality Effects 0.000 abstract 1
- 239000002872 contrast media Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000002059 diagnostic imaging Methods 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 238000001228 spectrum Methods 0.000 abstract 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
- A61K41/0033—Sonodynamic cancer therapy with sonochemically active agents or sonosensitizers, having their cytotoxic effects enhanced through application of ultrasounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Indole Compounds (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Microscoopes, Condenser (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09484318 | 2000-01-18 | ||
US09/484,318 US6180085B1 (en) | 2000-01-18 | 2000-01-18 | Dyes |
PCT/US2001/001469 WO2001052745A1 (fr) | 2000-01-18 | 2001-01-17 | Nouveaux colorants |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001232819A1 true AU2001232819A1 (en) | 2001-07-31 |
Family
ID=23923647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001232819A Abandoned AU2001232819A1 (en) | 2000-01-18 | 2001-01-17 | Novel dyes |
Country Status (8)
Country | Link |
---|---|
US (1) | US6180085B1 (fr) |
EP (2) | EP1250092B1 (fr) |
JP (1) | JP2003520288A (fr) |
AT (2) | ATE399505T1 (fr) |
AU (1) | AU2001232819A1 (fr) |
DE (2) | DE60134680D1 (fr) |
ES (2) | ES2309609T3 (fr) |
WO (1) | WO2001052745A1 (fr) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7255851B2 (en) * | 1994-07-01 | 2007-08-14 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive localization of a light-emitting conjugate in a mammal |
US6133445A (en) | 1997-12-17 | 2000-10-17 | Carnegie Mellon University | Rigidized trimethine cyanine dyes |
US6395257B1 (en) | 2000-01-18 | 2002-05-28 | Mallinckrodt Inc. | Dendrimer precursor dyes for imaging |
US7790144B2 (en) * | 2000-01-18 | 2010-09-07 | Mallinckrodt Inc. | Receptor-avid exogenous optical contrast and therapeutic agents |
US7230088B2 (en) | 2001-07-03 | 2007-06-12 | Mallinckrodt, Inc. | Compounds for dual photodiagnosis and therapy |
US6180085B1 (en) * | 2000-01-18 | 2001-01-30 | Mallinckrodt Inc. | Dyes |
US20030017164A1 (en) | 2001-07-03 | 2003-01-23 | Mallinckrodt Inc. | Dye-azide compounds for dual phototherapy |
US20080233050A1 (en) * | 2000-01-18 | 2008-09-25 | Mallinckrodt Inc. | Diagnostic and therapeutic optical agents |
US6939532B2 (en) * | 2000-01-18 | 2005-09-06 | Mallinckrodt, Inc. | Versatile hydrophilic dyes |
US6673334B1 (en) * | 2000-10-16 | 2004-01-06 | Mallinkcrodt, Inc. | Light sensitive compounds for instant determination of organ function |
US20070092450A1 (en) * | 2000-10-16 | 2007-04-26 | Mallinckrodt Inc. | Tissue-specific exogenous optical agents |
US20040180809A1 (en) * | 2000-10-16 | 2004-09-16 | Mallinckrodt Inc. | Tissue-specific exogenous optical agents |
US7556797B2 (en) * | 2000-10-16 | 2009-07-07 | Mallinckrodt Inc. | Minimally invasive physiological function monitoring agents |
US20030105299A1 (en) * | 2001-10-17 | 2003-06-05 | Mallinckrodt Inc. | Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |
US20030105300A1 (en) * | 2001-10-17 | 2003-06-05 | Mallinckrodt Inc. | Tumor targeted photodiagnostic-phototherapeutic agents |
ATE517152T1 (de) | 2002-05-10 | 2011-08-15 | Univ Carnegie Mellon | Chirale indole als zwischenprodukte und daraus hergestellte cyaninfluoreszenzfarbstoffe mit funktionellen gruppen |
US7226577B2 (en) | 2003-01-13 | 2007-06-05 | Bracco Imaging, S. P. A. | Gastrin releasing peptide compounds |
DE10302787A1 (de) * | 2003-01-24 | 2004-08-12 | Schering Ag | Hydrophile, Thiol-reaktive Cyaninfarbstoffe und deren Konjugate mit Biomolekülen für die Fluoreszenzdiagnostik |
ES2431520T3 (es) * | 2003-01-25 | 2013-11-26 | Seno Medical Instruments, Inc. | Procedimiento de formación de imágenes optoacústicas de contraste elevado utilizando nanopartículas no esféricas |
JP2007518727A (ja) * | 2004-01-08 | 2007-07-12 | ウニヴェルジテート・チューリッヒ | 配位子としてビタミンb12を有する金属錯体 |
DE102004002758A1 (de) * | 2004-01-20 | 2005-08-04 | Bayer Chemicals Ag | Metallkomplexe als lichtabsorbierende Verbindungen in der Informationsschicht von optischen Datenträgern |
US20100055040A1 (en) * | 2005-06-21 | 2010-03-04 | Periasamy Muthunadar P | Optical Imaging Contrast Agents |
US8227621B2 (en) * | 2005-06-30 | 2012-07-24 | Li-Cor, Inc. | Cyanine dyes and methods of use |
FR2889700B1 (fr) | 2005-08-11 | 2012-11-23 | Synthinnove Lab | Marqueurs, leur procede de fabrication et leurs applications |
US20100022449A1 (en) * | 2006-03-09 | 2010-01-28 | Mallinckrodt Inc. | Receptor-avid exogenous optical contrast and therapeutic agents |
US20110262354A1 (en) * | 2007-07-13 | 2011-10-27 | Emory University | Cyanine-containing compounds for cancer imaging and treatment |
US8088163B1 (en) | 2008-02-06 | 2012-01-03 | Kleiner Jeffrey B | Tools and methods for spinal fusion |
US20090214436A1 (en) | 2008-02-18 | 2009-08-27 | Washington University | Dichromic fluorescent compounds |
USD853560S1 (en) | 2008-10-09 | 2019-07-09 | Nuvasive, Inc. | Spinal implant insertion device |
US8864654B2 (en) | 2010-04-20 | 2014-10-21 | Jeffrey B. Kleiner | Method and apparatus for performing retro peritoneal dissection |
US9717403B2 (en) | 2008-12-05 | 2017-08-01 | Jeffrey B. Kleiner | Method and apparatus for performing retro peritoneal dissection |
US8366748B2 (en) | 2008-12-05 | 2013-02-05 | Kleiner Jeffrey | Apparatus and method of spinal implant and fusion |
USD656610S1 (en) | 2009-02-06 | 2012-03-27 | Kleiner Jeffrey B | Spinal distraction instrument |
US9247943B1 (en) | 2009-02-06 | 2016-02-02 | Kleiner Intellectual Property, Llc | Devices and methods for preparing an intervertebral workspace |
EP2419478B1 (fr) * | 2009-04-17 | 2018-02-28 | Li-Cor, Inc. | Imagerie de fluorescence avec des colorants de cyanine substituée |
WO2010129258A2 (fr) | 2009-04-27 | 2010-11-11 | Mallinckrodt Inc. | Compositions de scellement tissulaire, dispositifs de fermeture vasculaire et utilisations de ceux-ci |
US20170238984A1 (en) | 2009-09-18 | 2017-08-24 | Spinal Surgical Strategies, Llc | Bone graft delivery device with positioning handle |
USD750249S1 (en) | 2014-10-20 | 2016-02-23 | Spinal Surgical Strategies, Llc | Expandable fusion cage |
US9173694B2 (en) | 2009-09-18 | 2015-11-03 | Spinal Surgical Strategies, Llc | Fusion cage with combined biological delivery system |
US10973656B2 (en) | 2009-09-18 | 2021-04-13 | Spinal Surgical Strategies, Inc. | Bone graft delivery system and method for using same |
US9629729B2 (en) | 2009-09-18 | 2017-04-25 | Spinal Surgical Strategies, Llc | Biological delivery system with adaptable fusion cage interface |
US8685031B2 (en) | 2009-09-18 | 2014-04-01 | Spinal Surgical Strategies, Llc | Bone graft delivery system |
US9186193B2 (en) | 2009-09-18 | 2015-11-17 | Spinal Surgical Strategies, Llc | Fusion cage with combined biological delivery system |
USD723682S1 (en) | 2013-05-03 | 2015-03-03 | Spinal Surgical Strategies, Llc | Bone graft delivery tool |
US8906028B2 (en) | 2009-09-18 | 2014-12-09 | Spinal Surgical Strategies, Llc | Bone graft delivery device and method of using the same |
US10245159B1 (en) | 2009-09-18 | 2019-04-02 | Spinal Surgical Strategies, Llc | Bone graft delivery system and method for using same |
US9060877B2 (en) | 2009-09-18 | 2015-06-23 | Spinal Surgical Strategies, Llc | Fusion cage with combined biological delivery system |
US8690887B2 (en) * | 2010-02-08 | 2014-04-08 | Jeffrey B. Kleiner | Method and system for identification of a center of a vertebral disc space and corresponding central axis of a spinal column |
US9808320B2 (en) | 2010-02-08 | 2017-11-07 | Jeffrey B. Kleiner | Method and system for identification of a center of a patient's body part |
CN102260352B (zh) * | 2010-05-28 | 2013-11-20 | 山东先声麦得津生物制药有限公司 | 靶向性白细胞介素融合蛋白及其制备方法与应用 |
WO2012054784A1 (fr) | 2010-10-20 | 2012-04-26 | Li-Cor, Inc. | Imagerie de fluorescence à colorants à base de cyanine substituée |
WO2014013730A1 (fr) * | 2012-07-20 | 2014-01-23 | Canon Kabushiki Kaisha | Composé et milieu de contraste d'imagerie photoacoustique contenant le composé |
WO2014145898A2 (fr) | 2013-03-15 | 2014-09-18 | Glenn Lane Family Limited Liability Limited Partnership | Ouverture de résolution de masse ajustable |
US10806804B2 (en) * | 2015-05-06 | 2020-10-20 | Washington University | Compounds having RD targeting motifs and methods of use thereof |
USD797290S1 (en) | 2015-10-19 | 2017-09-12 | Spinal Surgical Strategies, Llc | Bone graft delivery tool |
US9862682B2 (en) | 2016-01-08 | 2018-01-09 | BroadPharm | Functionalized pegylated cyanine compounds, pharmaceutical compositions, and methods of use thereof |
KR101804063B1 (ko) | 2016-08-03 | 2017-12-01 | 전남대학교산학협력단 | 종양 표적화 근적외선 형광 탐지자 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4040825A (en) * | 1975-03-18 | 1977-08-09 | Ciba-Geigy Ag | Spectral sensitization of photographic material with natural colloids containing sensitizing dye groups |
DD256768B5 (de) * | 1984-09-27 | 1994-05-11 | Wolfen Filmfab Gmbh | Verfahren zum Einbringen von optischen Sensibilisatoren durch Dispergierung |
US5096801A (en) * | 1989-04-03 | 1992-03-17 | Fuji Photo Film Co., Ltd. | Color image recording method |
JPH03132654A (ja) * | 1989-10-18 | 1991-06-06 | Konica Corp | ハロゲン化銀カラー写真感光材料 |
JPH04186342A (ja) * | 1990-11-21 | 1992-07-03 | Fuji Photo Film Co Ltd | 写真感光材料を用いるカラープルーフの作成方法 |
JPH06102624A (ja) * | 1992-09-18 | 1994-04-15 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料 |
JPH0735749A (ja) * | 1993-07-19 | 1995-02-07 | Ibiden Co Ltd | O−アルキル化アミノグリカンを用いた免疫測定用標識試薬 |
JPH09227378A (ja) * | 1996-02-20 | 1997-09-02 | Fuji Photo Film Co Ltd | 抗癌性組成物 |
DE19649971A1 (de) * | 1996-11-19 | 1998-05-28 | Diagnostikforschung Inst | Optische Diagnostika zur Diagnostik neurodegenerativer Krankheiten mittels Nahinfrarot-Strahlung (NIR-Strahlung) |
ES2331671T3 (es) * | 1998-04-03 | 2010-01-12 | Mallinckrodt Inc. | Bioconjugados no covalentes utiles para diagnostico y terapia. |
DE19841985A1 (de) * | 1998-09-03 | 2000-03-09 | Schering Ag | Dialkylsulfonsäure- und Dialkylcarbonsäure-Derivate |
JP2000098524A (ja) * | 1998-09-25 | 2000-04-07 | Konica Corp | ハロゲン化銀乳剤、ハロゲン化銀感光材料及び熱現像感光材料 |
US6217848B1 (en) * | 1999-05-20 | 2001-04-17 | Mallinckrodt Inc. | Cyanine and indocyanine dye bioconjugates for biomedical applications |
US6180085B1 (en) * | 2000-01-18 | 2001-01-30 | Mallinckrodt Inc. | Dyes |
-
2000
- 2000-01-18 US US09/484,318 patent/US6180085B1/en not_active Expired - Fee Related
-
2001
- 2001-01-17 ES ES05005127T patent/ES2309609T3/es not_active Expired - Lifetime
- 2001-01-17 DE DE60134680T patent/DE60134680D1/de not_active Expired - Lifetime
- 2001-01-17 JP JP2001552800A patent/JP2003520288A/ja active Pending
- 2001-01-17 ES ES01904883T patent/ES2239122T3/es not_active Expired - Lifetime
- 2001-01-17 AT AT05005127T patent/ATE399505T1/de not_active IP Right Cessation
- 2001-01-17 EP EP01904883A patent/EP1250092B1/fr not_active Expired - Lifetime
- 2001-01-17 DE DE60109740T patent/DE60109740T8/de active Active
- 2001-01-17 AU AU2001232819A patent/AU2001232819A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001469 patent/WO2001052745A1/fr active IP Right Grant
- 2001-01-17 EP EP05005127A patent/EP1559374B1/fr not_active Expired - Lifetime
- 2001-01-17 AT AT01904883T patent/ATE291878T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1250092B1 (fr) | 2005-03-30 |
ATE399505T1 (de) | 2008-07-15 |
WO2001052745A1 (fr) | 2001-07-26 |
JP2003520288A (ja) | 2003-07-02 |
EP1250092A4 (fr) | 2003-05-07 |
EP1559374A1 (fr) | 2005-08-03 |
DE60109740D1 (de) | 2005-05-04 |
EP1559374B1 (fr) | 2008-07-02 |
ATE291878T1 (de) | 2005-04-15 |
EP1250092A1 (fr) | 2002-10-23 |
DE60134680D1 (de) | 2008-08-14 |
DE60109740T2 (de) | 2006-02-23 |
DE60109740T8 (de) | 2006-04-27 |
US6180085B1 (en) | 2001-01-30 |
ES2309609T3 (es) | 2008-12-16 |
ES2239122T3 (es) | 2005-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001232819A1 (en) | Novel dyes | |
AU2001232820A1 (en) | Novel indocyanine dyes | |
Keereweer et al. | Optical image-guided cancer surgery: challenges and limitations | |
Mahmood et al. | Near-infrared optical imaging of protease activity for tumor detection | |
Moore et al. | Strategies for image-guided therapy, surgery, and drug delivery using photoacoustic imaging | |
WO2005000218A3 (fr) | Bioconjugues macrocycliques a base de cyanine et d'indocyanine pour applications biomedicales ameliorees | |
Gioux et al. | Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation | |
Yim et al. | Optimization of a protease activated probe for optical surgical navigation | |
DK1178830T3 (da) | Cyanin- og indocyaninfarvestof-biokonjugater til biomedicinske anvendelser | |
Keereweer et al. | Optical image-guided surgery—where do we stand? | |
Keereweer et al. | Image‐guided surgery in head and neck cancer: current practice and future directions of optical imaging | |
Sajedi et al. | Intraoperative biophotonic imaging systems for image-guided interventions | |
DK1698350T3 (da) | Porphyrinbaserede forbindelser til billeddiagnostisk tumorundersögelse og fotodynamisk terapi | |
Miwa | The principle of ICG fluorescence method | |
ATE518477T1 (de) | Fluoreszenzvermittelte molekulartomographie | |
Hamblin et al. | Imaging in photodynamic therapy | |
EP1250095A4 (fr) | Colorants hydrophiles versatiles | |
Napp et al. | Optical imaging in vivo with a focus on paediatric disease: technical progress, current preclinical and clinical applications and future perspectives | |
Ntziachristos | Clinical translation of optical and optoacoustic imaging | |
Obaid et al. | Activatable clinical fluorophore-quencher antibody pairs as dual molecular probes for the enhanced specificity of image-guided surgery | |
Khan et al. | Clinical assessment of a low-cost, hand-held, smartphone-attached intraoral imaging probe for 5-aminolevulinic acid photodynamic therapy monitoring and guidance | |
Hegyi et al. | New developments in fluorescence diagnostics | |
Stater et al. | The present and future of optical imaging technologies in the clinic: diagnosis and therapy | |
Wilson et al. | Nanoparticle-enabled optical endoscopy: extending the frontiers of diagnosis and treatment | |
Liu et al. | Looking out the optical window: Physical principles and instrumentation of imaging in photodynamic therapy |